Reduction of Acetate and Lactate Contributed to Enhancement of a Recombinant Protein Production in E. coli BL21

被引:25
|
作者
Kim, Tae-Su [1 ,2 ]
Jung, Hyung-Moo [3 ]
Kim, Sang-Yong [3 ]
Zhang, Liaoyuan [1 ]
Li, Jinglin [1 ]
Sigdel, Sujan [1 ]
Park, Ji-Hyun [1 ]
Haw, Jung-Rim [2 ]
Lee, Jung-Kul [1 ]
机构
[1] Konkuk Univ, Dept Chem Engn, Seoul 143701, South Korea
[2] Konkuk Univ, Inst SK KU Biomat, Seoul 143701, South Korea
[3] BioNgene Co Ltd, Seoul 110521, South Korea
基金
新加坡国家研究基金会;
关键词
Large-scale bioreactor; maltogenic amylase; metabolically engineered; production; recombinant protein; FED-BATCH CULTURES; ESCHERICHIA-COLI; METABOLIC-RESPONSE; EXPRESSION; PHOSPHOTRANSACETYLASE; IMMOBILIZATION; AMYLASE; DEHYDROGENASE; PROFILES; IMPROVES;
D O I
10.4014/jmb.1503.03023
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Acetate and lactate in growth media are detrimental to the production of Thermus maltogenic amylase (ThMA), a heterologous protein, as well as to the growth of recombinant Escherichia coli. Only 50 mM of acetate or 10 mM of lactate reduced 90% of specific ThMA activity. In this study, mutant E. coli strains blocked in the ackA-pta or ackA-pta and ldh pathways were created, characterized, and assessed for their culture performace in 300 L-scale fermentation. The ackA-pta and ldh double-mutant strain formed significantly less lactate and acetate, and produced a concomitant increase in the excretion of pyruvate (17.8 mM) under anaerobic conditions. The ackA-pta mutant strain accumulated significant acetate but had an approximately 2-fold increase in the formation of lactate. The ackA-pta and ldh double-mutant strain had superior overall performance in large-scale culture under suboptimal conditions, giving 67% higher cell density and 66% higher ThMA activity compared with those of the control strain. The double-mutant strain also achieved a 179% improvement in volumetric ThMA production.
引用
收藏
页码:1093 / 1100
页数:8
相关论文
共 50 条
  • [21] Regulating the T7 RNA polymerase expression in E. coli BL21 (DE3) to provide more host options for recombinant protein production
    Du, Fei
    Liu, Yun-Qi
    Xu, Ying-Shuang
    Li, Zi-Jia
    Wang, Yu-Zhou
    Zhang, Zi-Xu
    Sun, Xiao-Man
    MICROBIAL CELL FACTORIES, 2021, 20 (01)
  • [22] Regulation of acetate metabolism in Escherichia coli BL21 by protein Nε-lysine acetylation
    Sara Castaño-Cerezo
    Vicente Bernal
    Teresa Röhrig
    Svenja Termeer
    Manuel Cánovas
    Applied Microbiology and Biotechnology, 2015, 99 : 3533 - 3545
  • [23] Engineered production of 5-aminolevulinic acid in recombinant Escherichia coli BL21
    Zhu, Zhiwen
    Fu, Bing
    Lu, Jiajie
    Wang, Peize
    Yan, Chuyang
    Guan, Fuyao
    Huang, Jianying
    Yu, Ping
    PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY, 2024,
  • [24] Batch production of a silk-elastin-like protein in E. coli BL21(DE3): key parameters for optimisation
    Tony Collins
    João Azevedo-Silva
    André da Costa
    Fernando Branca
    Raul Machado
    Margarida Casal
    Microbial Cell Factories, 12
  • [25] Growth and proton exchange in recombinant Escherichia coli BL21
    Christensen, ML
    Eriksen, NT
    ENZYME AND MICROBIAL TECHNOLOGY, 2002, 31 (04) : 566 - 574
  • [26] Batch production of a silk-elastin-like protein in E. coli BL21 (DE3): key parameters for optimisation
    Collins, Tony
    Azevedo-Silva, Joao
    da Costa, Andre
    Branca, Fernando
    Machado, Raul
    Casal, Margarida
    MICROBIAL CELL FACTORIES, 2013, 12
  • [27] Purification and enzymatic properties of arsenic resistance protein ArsH from heterogeneous expression in E. coli BL21
    Wu Xue-ling
    Miao Bo
    Han Jian
    Hu Qi
    Zeng Jia
    Liu Yuan-dong
    Qiu Guan-zhou
    TRANSACTIONS OF NONFERROUS METALS SOCIETY OF CHINA, 2010, 20 (10) : 1987 - 1992
  • [29] Acetate accumulation through alternative metabolic pathways in ackA−pta−poxB− triple mutant in E. coli B (BL21)
    Je-Nie Phue
    Sang Jun Lee
    Jeanne B. Kaufman
    Alejandro Negrete
    Joseph Shiloach
    Biotechnology Letters, 2010, 32 : 1897 - 1903
  • [30] Galactose can be an inducer for production of therapeutic proteins by auto-induction using E. coli BL21 strains
    Xu, Jianlin
    Banerjee, Akhilesh
    Pan, Shih-Hsie
    Li, Zheng Jian
    PROTEIN EXPRESSION AND PURIFICATION, 2012, 83 (01) : 30 - 36